Navigation Links
Landmark Trial Provides Vital Information for Cardiac Disease Treatment
Date:2/18/2009

er, heart, orthopaedics, high-risk maternity and pediatrics. NorthShore is a national leader in the implementation of innovative technologies, including electronic medical records, (EMR ). In 2003, the healthsystem was among the first in the country to successfully launch a systemwide EMR with demonstrable benefits in quality, safety, efficiency and service to patients. NorthShore has been recognized by multiple national organizations for this notable achievement. Visit http://www.northshore.org/

CONTACT: Amy Ferguson
Senior Director, Public Relations
NorthShore University HealthSystem
(847) 570-3146


###

Read the full story at http://www.prweb.com/releases/2009/02/prweb2114514.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Document Security Systems (Amex: DMC) Invites You to a Landmark Event
2. Less than one-third of women aware of landmark hormone therapy study, Stanford researcher finds
3. Pathway to cell death redefined in landmark study
4. Pathway to cell death redefined in landmark study
5. UCLA to lead local study center in landmark government study of child health
6. Landmark Report: Excess Body Fat Causes Cancer
7. In Landmark Phase III Head-to-Head Study, Prasugrel Statistically Superior to Clopidogrel in Reducing Risk of Heart Attack
8. Landmark trial to evaluate cardioprotective properties of insulin
9. Safeway Inc. and the Prostate Cancer Foundation to Fund Landmark Prostate Cancer Research Collaboration
10. Yale launches landmark VIRGO study of young women with heart disease
11. Hospital Launches Landmark Project in Emergency Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Landmark Trial Provides Vital Information for Cardiac Disease Treatment
(Date:8/28/2015)... ... 28, 2015 , ... The 6th Annual Survivor in the City, Chicago ... yet another accolade to its cadre of widespread support—an official letter of support and ... of the medical community and the University of Illinois at Chicago’s Department of Neurosurgery, ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... On May ... Michigan, joined as sponsor of the “Music With A Mission” benefit concert in Mendon, ... the event was to raise money to support music education programs in the underfunded ...
(Date:8/28/2015)... ... August 28, 2015 , ... Loved ... might personally be struggling with chemical dependency, may be able to find some ... a results-driven holistic treatment center for addiction located in Western Michigan. Focusing on ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... of high grade protein with zero fat, carbs, sugar, gluten, lactose or caffeine ... a finalist for the 2015 SupplySide CPG Editor’s Choice Awards. , Five consumer ...
(Date:8/28/2015)... ... August 28, 2015 , ... “ Frequentz ” was featured on ... and coolest applications on the market for iOS, Android, and Windows. Joe Toohey, the ... how this software allows businesses to track product movement from beginning to end. , ...
Breaking Medicine News(10 mins):Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 3Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:Track Product Movement from Beginning to End with Frequentz 2
... to feature Mayo Clinic ... ... ulcerative,colitis patients, caregivers, and healthcare professionals can now register,for "Inflammatory Bowel ... through the Crohn,s & Colitis,Foundation will take place on Thursday, March ...
... Jan. 29 The Board of,Directors of BD (Becton, ... a,quarterly dividend of 28.5 cents per common share. The ... of record on March 10, 2008. The,indicated annual dividend ... BD, a leading global medical technology company that manufactures ...
... with NBME and Announces ... Program, TAMPA, Fla., Jan. 29 The ... Inc. (ABQAURP) is pleased to,announce the organization has ... Examiners(R) (NBME(SM)) to oversee and administer ABQAURP,s,professional certification ...
... Disorders and Stroke has awarded $1.7 million to University of ... Americans $50 billion a yearlow back pain. , Back pain ... 45 years old and is experienced by 50 to 80 ... pain becomes chronic if it persists for more than three ...
... Stephen J. Ubl,president and CEO of AdvaMed, issued ... Commerce Oversight and Investigations,Subcommittee hearing on the recent ... at Risk: FDA,s Self-Assessment":, "The Food and ... bearer for safety, but critical steps must be ...
... Arcadian Health Plan, Inc., a,leading provider of ... its benefits for 2008 and expanded into the,state ... successful rollouts in,Oklahoma, Georgia, South Carolina and Maine., ... premiums, free annual,physicals and flu shots, dental benefits, ...
Cached Medicine News:Health News:Interactive Teleconference on Inflammatory Bowel Disease for Patients, Caregivers, and Healthcare Professionals 2Health News:ABQAURP Renews Agreement with the National Board of Medical Examiners to Oversee Testing Methodology 2Health News:ABQAURP Renews Agreement with the National Board of Medical Examiners to Oversee Testing Methodology 3Health News:UC scientists awarded $1.7 million for low back pain research 2Health News:AdvaMed Supports Increased Funding for FDA 2Health News:Bright Options for Medicare Beneficiaries in Louisiana 2
(Date:8/28/2015)... , Aug. 28, 2015 Patterson Medical, ... (Nasdaq: PDCO ), is now an independent ... acquisition of Patterson Medical by Madison Dearborn Partners ... its name for a transition period before rebranding ... and sports medicine products.  With the focused resources ...
(Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "Investigation Report ... their offering. Developed by AstraZeneca plc, ... an important drug for the treatment of schizophrenia. ... quetiapine was listed in the Catalogue of Drugs ...
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on ... their offering. Developed by Novo Nordisk, ... is an important drug for the treatment of ... a fast- acting insulin analog, starts working fast ...
Breaking Medicine Technology:Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3China Quetiapine Market Investigation Report 2010-2019 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2
... -- Peregrine,s Second Phase II Bavituximab Cancer Trial Is Evaluating the, ... ... Paclitaxel --, TUSTIN, Calif., June 30 Peregrine,Pharmaceuticals, Inc. ... in a Phase II trial designed to evaluate the safety,and efficacy of ...
... Meeting with FDA Set for Sept. 29, ... (Nasdaq: TPTX ) today announced that data ... American Headache Society showed that, in,addition to meeting ... two,hours, the company,s lead AMPA/kainate-type glutamate receptor antagonist,tezampanel, ...
Cached Medicine Technology:Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 2Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 3Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 4Data Presented at American Headache Society's Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics' Tezampanel 2Data Presented at American Headache Society's Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics' Tezampanel 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: